英文互译镜像站

Davunetide

Last updated

Davunetide
Davunetide structure.png
Identifiers
  • (2S)-5-amino-2-[[(2S)-1-[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2,4-diamino-4-oxobutanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]amino]-3-hydroxypropanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoic acid
CAS Number
PubChem CID
Chemical and physical data
Formula C36H60N10O12
Molar mass 824.934 g·mol−1
3D model (JSmol)
  • CC[C@H](C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]2CCCN2C(=O)[C@H](C)NC(=O)[C@H](CC(=O)N)N
  • InChI=1S/C36H60N10O12/c1-6-18(4)28(35(56)46-14-8-9-23(46)31(52)41-21(36(57)58)11-12-25(38)48)44-30(51)22(16-47)42-33(54)27(17(2)3)43-32(53)24-10-7-13-45(24)34(55)19(5)40-29(50)20(37)15-26(39)49/h17-24,27-28,47H,6-16,37H2,1-5H3,(H2,38,48)(H2,39,49)(H,40,50)(H,41,52)(H,42,54)(H,43,53)(H,44,51)(H,57,58)/t18-,19-,20-,21-,22-,23-,24-,27-,28-/m0/s1
  • Key:DWLTUUXCVGVRAV-XWRHUKJGSA-N

Davunetide (Asn-Ala-Pro-Val-Ser-Ile-Pro-Gln, CP201) is a octapeptide derivative with the amino acid sequence NAPVSIPQ. It has antiinflammatory and neuroprotective effects and has been investigated for several conditions including schizophrenia and Alzheimer's Disease. [1] [2] [3] [4] [5] [6] [7]

See also

References

  1. ↑ Gozes I (2011). "NAP (davunetide) provides functional and structural neuroprotection". Current Pharmaceutical Design. 17 (10): 1040–1044. doi:10.2174/138161211795589373. PMID   21524250.
  2. ↑ Gozes I (January 2017). "Sexual divergence in activity-dependent neuroprotective protein impacting autism, schizophrenia, and Alzheimer's disease". Journal of Neuroscience Research. 95 (1–2): 652–660. doi:10.1002/jnr.23808. PMID   27870441.
  3. ↑ Gozes I (2020). "The ADNP Syndrome and CP201 (NAP) Potential and Hope". Frontiers in Neurology. 11 608444. doi: 10.3389/fneur.2020.608444 . PMC   7732499 . PMID   33329371.
  4. ↑ Ivashko-Pachima Y, Gozes I (2021). "Activity-dependent neuroprotective protein (ADNP)-end-binding protein (EB) interactions regulate microtubule dynamics toward protection against tauopathy". Progress in Molecular Biology and Translational Science. 177: 65–90. doi:10.1016/bs.pmbts.2020.07.008. ISBN   978-0-12-824143-1. PMID   33453943.
  5. ↑ D'Amico AG, Maugeri G, Musumeci G, Reglodi D, D'Agata V (August 2021). "PACAP and NAP: Effect of Two Functionally Related Peptides in Diabetic Retinopathy". Journal of Molecular Neuroscience. 71 (8): 1525–1535. doi:10.1007/s12031-020-01769-4. PMID   33403597.
  6. ↑ Bhargava S, Kulkarni R, Dewangan B, Kulkarni N, Jiaswar C, Kumar K, et al. (November 2023). "Microtubule stabilising peptides: new paradigm towards management of neuronal disorders". RSC Medicinal Chemistry. 14 (11): 2192–2205. doi:10.1039/d3md00012e. PMC   10650357 . PMID   37974959.
  7. ↑ Galushkin A, Gozes I (May 2025). "Intranasal NAP (Davunetide): Neuroprotection and circadian rhythmicity". Advanced Drug Delivery Reviews. 220 115573. doi: 10.1016/j.addr.2025.115573 . PMID   40185278.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.
镜像小偷 时间因子转换镜像 递归网站下载 镜像站群霸屏 整站下载器